Literature DB >> 2233084

Esthesioneuroblastoma: surgical treatment without radiation.

H F Biller1, W Lawson, V P Sachdev, P Som.   

Abstract

This study compares the treatment of two groups of patients diagnosed with esthesioneuroblastoma limited to the nasal cavity without evidence of cribriform plate erosion. Five patients were treated with radiation and extracranial excision, and eight patients were treated by craniofacial resection only. The incidences of local recurrence were 60% and 12%, respectively. The paper also presents a new staging classification for these tumors.

Entities:  

Mesh：

Year:  1990        PMID： 2233084     DOI： 10.1288/00005537-199011000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


  33 in total

Review 1.  Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature.

Authors:  Michael C Park; Charles E Weaver; John E Donahue; Prakash Sampath
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

2.  Transcranial resection of olfactory neuroblastoma.

Authors:  Chih-Chun Wang; Yao-Liang Chen; Yung-Shin Hsu; Shih-Ming Jung; Sheng-Po Hao
Journal:  Skull Base       Date:  2005-08

3.  Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the m.d. Anderson cancer center.

Authors:  J R Austin; H Cebrun; M M Kershisnik; A K El-Naggar; A S Garden; F Demonte; L E Ginsberg; S M Lippman; H Goepfert
Journal:  Skull Base Surg       Date:  1996

4.  Olfactory neuroblastomas: survival rate and prognostic factor.

Authors:  Sung-Kyun Hwang; Sun-Ha Paek; Dong Gyu Kim; Yoon-Kyung Jeon; Je G Chi; Hee-Won Jung
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 5.  Retropharyngeal lymph node metastasis from esthesioneuroblastoma: a review of the therapeutic and prognostic implications.

Authors:  L V Zollinger; R H Wiggins; R S Cornelius; C D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

Review 6.  Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.

Authors:  Rami E Saade; Ehab Y Hanna; Diana Bell
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

7.  When is surgical therapy for head and neck malignant epithelial tumors not indicated?

Authors:  Carlos Suárez; Robert P Takes; Carl E Silver; Juan P Rodrigo; Primož Strojan; Julia A Woolgar; Missak Haigentz; H Hakan Coskun; Remco de Bree; Randall P Owen; Mohamed N Elsheikh; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-04       Impact factor: 2.503

8.  Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013.

Authors:  Bobby A Tajudeen; Armin Arshi; Jeffrey D Suh; Miguel Fernando Palma-Diaz; Marvin Bergsneider; Elliot Abemayor; Maie St John; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-13

9.  Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.

Authors:  Neeraja Konuthula; Alfred M Iloreta; Brett Miles; Ryan Rhome; Umut Ozbek; Eric M Genden; Marshall Posner; Krzysztof Misiukiewicz; Satish Govindaraj; Raj Shrivastava; Vishal Gupta; Richard L Bakst
Journal:  Head Neck       Date:  2017-08-17       Impact factor: 3.147

10.  Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives.

Authors:  Robbie S R Woods; Thavakumar Subramaniam; Mary Leader; Rory McConn-Walsh; James Paul O'Neill; Peter D Lacy
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.